Dec 16 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and Metachromatic Leukodystrophy, to the federal newborn screening list to enable early treatment, the Department of Health and Human Services said.
The decision updates the Recommended Uniform Screening Panel (RUSP), which guides state-level newborn screening programs, following a scientific review and public comment process.
Early detection of Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD) will allow children to receive FDA-approved therapies at the most effective time, helping slow disease progression and preserve quality of life, the HHS said.
DMD, a rare genetic disorder, causes muscle degeneration, while MLD affects the brain and nervous system, which leads to loss of motor and cognitive function and early death.
Most children with DMD or MLD are diagnosed at age four or five, when significant muscle loss or neurological decline has already occurred, the HHS said.
The agency said that screening at birth could reduce years-long diagnostic delays, repeated specialist visits, and the financial and emotional strain often associated with rare diseases.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini Ganguli)
Scientists map of old Mars river basins for the 1st time. These could be great places to search for ancient life- NASA releases stunning first images of Earth taken by the Artemis II astronauts
- Doulas play essential roles in reproductive health care – and more states are beginning to recognize it
- Russia earning billions from Hormuz blockade, German trade body says
- Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- Turning into a Distributed Writer: My Composing Process
- Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- US FDA investigates Takeda's blood disorder drug after pediatric death
- Space Condos to Lift Your Metropolitan Living
